Literature DB >> 10980328

Serum interleukin-18 levels are elevated in schizophrenia.

K F Tanaka1, F Shintani, Y Fujii, G Yagi, M Asai.   

Abstract

Interleukin-18 (IL-18) is a recently discovered proinflammatory cytokine which plays a pivotal role in T helper 1 (Th1) responses. IL-18 is produced by macrophage-like cells, and inappropriate IL-18 production has been known to be involved in immunological disturbances. Schizophrenia is a common disease whose pathogenesis is still unclear; however, an activation of the inflammatory response system, including the Th1 cytokine response, may be related to the pathophysiology of schizophrenia. We measured the serum IL-18 levels of 66 schizophrenics and age- and sex-matched control subjects by using an ELISA assay. We found significantly increased serum IL-18 levels in the schizophrenic patients (P=0.0002). This finding supports the hypothesis that immune activation is involved in the pathophysiology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980328     DOI: 10.1016/s0165-1781(00)00196-7

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  16 in total

Review 1.  [Immunology in schizophrenic disorders].

Authors:  N Müller; M J Schwarz
Journal:  Nervenarzt       Date:  2007-03       Impact factor: 1.214

2.  Immune System and Schizophrenia.

Authors:  Norbert Müller; Markus J Schwarz
Journal:  Curr Immunol Rev       Date:  2010-08

Review 3.  Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission.

Authors:  N Muller; M Schwarz
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

Review 4.  Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications.

Authors:  Barbara Sperner-Unterweger
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 5.  Interleukin 18 in the CNS.

Authors:  Silvia Alboni; Davide Cervia; Shuei Sugama; Bruno Conti
Journal:  J Neuroinflammation       Date:  2010-01-29       Impact factor: 8.322

6.  Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain.

Authors:  Silvia Alboni; Davide Cervia; Brendon Ross; Claudia Montanari; Alejandro Sanchez Gonzalez; Manuel Sanchez-Alavez; Maria Cecilia Garibaldi Marcondes; David De Vries; Shuei Sugama; Nicoletta Brunello; Joan Blom; Fabio Tascedda; Bruno Conti
Journal:  J Neuroimmunol       Date:  2009-07-28       Impact factor: 3.478

Review 7.  [Cytokine network in patients with schizophrenia and its significance for the pathophysiology of the illness].

Authors:  A Schuld; D Hinze-Selch; Th Pollmächer
Journal:  Nervenarzt       Date:  2004-03       Impact factor: 1.214

8.  Relationship of serum levels of TNF-α, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers.

Authors:  Ni Fan; Yayan Luo; Ke Xu; Minling Zhang; Xiaoyin Ke; Xini Huang; Yi Ding; Daping Wang; Yuping Ning; Xuefeng Deng; Hongbo He
Journal:  Schizophr Res       Date:  2015-11-14       Impact factor: 4.939

Review 9.  Markers of vulnerability in schizophrenia.

Authors:  Maria Ladea; Dan Prelipceanu
Journal:  J Med Life       Date:  2009 Apr-Jun

10.  Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophrenia.

Authors:  Ilaria Palladino; Francesca Salani; Antonio Ciaramella; Ivo Alex Rubino; Carlo Caltagirone; Sabrina Fagioli; Gianfranco Spalletta; Paola Bossù
Journal:  J Neuroinflammation       Date:  2012-08-22       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.